Figure Legends
Fig. 1A. Peripheral blood film showing multiple rouleaux,
morphologically normal WBC and platelets. May-Giemsa, x100 objective.
Fig. 1B. Bone marrow aspirate with numerous plasma cells, comprising
over 90% of bone marrow cells, reduced erythopoiesis, granulopoiesis
and thrombopoiesis. Plasma cells contain Dutcher bodies and Russell
bodies. H&E, x200 objective.
Fig. 1C. Strong expression of CD138 on plasma cell surface. Clot
section, H&E, x200 objective.
Fig. 2. Graphical changes over time in patient’s, hemoglobin, platelet
counts, and affected free light chain over the course of disease and
anti-myeloma therapy. Hb, Hemoglobin (g/L); Plt, platelet count
(x109/L), FLC, serum free light chain (mg/L); MPV,
Melphalan, Prednisone, Velcade (Bortezomib); Ld, Lenalidomide and
dexamethasone; DVd, Daratumumab, Velcade (Bortezomib), dexamethasone;
PCd, Pomalidomide, Cyclophosphamide, dexamethasone; Id, Ixazomib,
dexamethasone.